A drug with the SMILES CCN1CCN(c2nc(N)c([N+](=O)[O-])c(Nc3cccc(C)c3)n2)CC1 has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM of -45.008%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCN1CCN(c2nc(N)c([N+](=O)[O-])c(Nc3cccc(C)c3)n2)CC1
CCN1CCN(c2nc(N)c([N+](=O)[O-])c(Nc3cccc(C)c3)n2)CC1
2-(4-ethylpiperazin-1-yl)-4-N-(3-methylphenyl)-5-nitropyrimidine-4,6-diamine